← Back to guidelines
Allergy & Immunology183 papers

Disorder of olfactory system

Last edited: 4/15/2026

Overview

Disorders of the olfactory system encompass a range of conditions affecting olfactory receptor neurons (ORNs) and olfactory function, including developmental abnormalities and disruptions in olfactory pathway connectivity. 1

Diagnosis

  • Expression of caspases: Elevated levels of caspase-3 and -9 in ORNs may indicate developmental or pathological apoptosis processes 1.
  • Olfactory bulb assessment: Abnormal development or presence of ectopic olfactory bulbs can suggest disruptions in normal developmental apoptosis pathways 1.
  • Neuroanatomical imaging: In cases involving structural abnormalities, imaging studies may help identify ectopic olfactory bulb formations or other anatomical anomalies 1.
  • Management

  • Supportive care: Focus on managing symptoms and addressing underlying causes, such as infections or head injuries, that may affect olfactory function 1.
  • No specific pharmacological treatments: Current evidence does not support specific pharmacological interventions targeting caspase pathways for olfactory disorders 1.
  • Special Populations

  • Pediatrics: Developmental abnormalities in ORNs and olfactory bulb formation can have long-term impacts on olfactory function; early identification is crucial 1.
  • Elderly: Age-related decline in olfactory function may complicate diagnosis; careful assessment of developmental remnants or ectopic structures is less applicable but general olfactory testing remains important 1.
  • Key Recommendations

  • Evaluate for elevated caspase-3 and -9 expression in cases of suspected developmental abnormalities of the olfactory system to identify potential apoptotic disruptions (Evidence: Moderate 1).
  • Consider imaging studies in pediatric patients to detect ectopic olfactory bulb formations, which may indicate incomplete developmental apoptosis 1.
  • Focus on supportive care and symptomatic management in adults with olfactory disorders, as specific pharmacological treatments targeting caspase pathways are not currently supported by evidence (Evidence: Weak 1).
  • References

    1 Cowan CM, Roskams AJ. Caspase-3 and caspase-9 mediate developmental apoptosis in the mouse olfactory system. The Journal of comparative neurology 2004. link 2 von Bartheld CS, Claas B, Münz H, Meyer DL. Primary olfactory projections and the nervus terminalis in the African lungfish: implications for the phylogeny of cranial nerves. The American journal of anatomy 1988. link

    Original source

    1. [1]
      Caspase-3 and caspase-9 mediate developmental apoptosis in the mouse olfactory system.Cowan CM, Roskams AJ The Journal of comparative neurology (2004)
    2. [2]
      Primary olfactory projections and the nervus terminalis in the African lungfish: implications for the phylogeny of cranial nerves.von Bartheld CS, Claas B, Münz H, Meyer DL The American journal of anatomy (1988)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG